Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
Yun Liu(Jiangnan University), Andrew P. Feinberg(Johns Hopkins University), Leonid Padyukov(Karolinska University Hospital), Marcus Ronninger(Karolinska Institutet), Tomas J. Ekström(Karolinska Institutet), Martin J. Aryee(Johns Hopkins University), Lovisa E. Reinius(Karolinska Institutet), Árni Rafn Rúnarsson(Johns Hopkins University), Espen Hesselberg(Karolinska Institutet), Nathalie Acevedo(Karolinska Institutet), Lars Alfredsson(University of Helsinki), Lars Klareskog(Karolinska University Hospital), Annika Scheynius(Stockholm South General Hospital), Klementy Shchetynsky(Karolinska University Hospital), M. Daniele Fallin(Emory University), Juha Kere(University of Helsinki), Margaret A. Taub(Johns Hopkins University)
Cited by 1,032
Related Papers
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k